Model
Edge
Enzon Pharmaceuticals, Inc.
0001571659
Filing Type
4/A
Filing Date
3/30/2020
Updated
3/31/20, 12:34 PM
Filing
4/A
Earnings Release
Exhibits
4/A
Amended Statement of Changes in Beneficial Ownership